A newly developed glucagon sandwich <scp>ELISA</scp> is useful for more accurate glucagon evaluation than the currently used sandwich <scp>ELISA</scp> in subjects with elevated plasma proglucagon‐derived peptide levels

Abstract

The new ELISA enables more accurate measurement of plasma glucagon than the currently used ELISA, even in subjects with elevated proglucagon-derived peptide levels. It should be clinically useful in elucidating the pathophysiology of individual diabetic patients.